Merger Notification - Announcement according to § 10 Cartel Act
Raiffeisen Continuum Group; SPLIPHARM Arzneiwaren HandelsgmbH; S-Mgmt Investment AG
BWB/Z-7035
On 08.08.2025 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Raiffeisen Continuum Holding GmbH intends to increase its existing stake in SPLIPHARM Arzneiwaren HandelsgmbH from 35% to 55%. The proposed transaction concerns the wholesale of pharmaceuticals.
NACE: Wholesale of pharmaceutical, medical and orthopaedic products
G - WHOLESALE AND RETAIL TRADE G 46 - Wholesale trade, G 46.4 - Wholesale of household goods, G 46.46 - Wholesale of pharmaceutical and medical goods
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 05.09.2025.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 06.09.2025 .